Agomab Announces Pricing of Initial Public Offering

ANTWERP, Belgium, February 5, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with

End of Day Message

LONDON, 05 Feb. 2026 (GLOBE NEWSWIRE) — This is the End of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved

Update in Sampo’s distribution policy

Sampo plc, stock exchange release, 5 February 2026 at 8.20 am EET Update in Sampo’s distribution policy To enable Sampo to continue to deliver an attractive mix of dividends and

Scroll to Top